166 related articles for article (PubMed ID: 6261180)
1. Hypothalamic catecholamine levels in dogs with spontaneous hyperadrenocorticism.
Meijer JC; Croughs RJ; Rijnberk A; Versteeg DH; van Ree JM
Neuroendocrinology; 1981 Apr; 32(4):197-201. PubMed ID: 6261180
[TBL] [Abstract][Full Text] [Related]
2. Urinary corticoid/creatinine ratios in the differentiation between pituitary-dependent hyperadrenocorticism and hyperadrenocorticism due to adrenocortical tumour in the dog.
Galac S; Kooistra HS; Teske E; Rijnberk A
Vet Q; 1997 Mar; 19(1):17-20. PubMed ID: 9225424
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic corticotrophin releasing factor activity in dogs with pituitary-dependent hyperadrenocorticism.
Meijer JC; Mulder GH; Rijnberk A; Croughs RJ
J Endocrinol; 1978 Nov; 79(2):209-13. PubMed ID: 215690
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a six-hour combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.
Feldman EC
J Am Vet Med Assoc; 1986 Dec; 189(12):1562-6. PubMed ID: 3025143
[TBL] [Abstract][Full Text] [Related]
5. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS
J Am Vet Med Assoc; 1996 Aug; 209(4):772-5. PubMed ID: 8756877
[TBL] [Abstract][Full Text] [Related]
6. Responsiveness to corticotropin-releasing hormone and vasopressin in canine Cushing's syndrome.
van Wijk PA; Rijnberk A; Croughs RJ; Wolfswinkel J; Selman PJ; Mol JA
Eur J Endocrinol; 1994 Apr; 130(4):410-6. PubMed ID: 8162173
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS; Farver TB
J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
[TBL] [Abstract][Full Text] [Related]
8. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia.
Norman EJ; Thompson H; Mooney CT
Vet Rec; 1999 May; 144(20):551-4. PubMed ID: 10371012
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
Mack RE; Feldman EC
J Am Vet Med Assoc; 1990 Dec; 197(12):1603-6. PubMed ID: 2177458
[TBL] [Abstract][Full Text] [Related]
10. Hyperadrenocorticism in a dog due to ectopic secretion of adrenocorticotropic hormone.
Galac S; Kooistra HS; Voorhout G; van den Ingh TS; Mol JA; van den Berg G; Meij BP
Domest Anim Endocrinol; 2005 Apr; 28(3):338-48. PubMed ID: 15760674
[TBL] [Abstract][Full Text] [Related]
11. Secretion of sex hormones in dogs with adrenal dysfunction.
Hill KE; Scott-Moncrieff JC; Koshko MA; Glickman LT; Glickman NW; Nelson RW; Blevins WE; Oliver JW
J Am Vet Med Assoc; 2005 Feb; 226(4):556-61. PubMed ID: 15742696
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.
Feldman EC
J Am Vet Med Assoc; 1985 Jul; 187(1):49-53. PubMed ID: 2991177
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of cortisol and cortisone in healthy dogs and dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE
Vet Rec; 2008 Oct; 163(16):477-81. PubMed ID: 18931355
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing hormone and adrenocorticotropic hormone concentrations in cerebrospinal fluid of dogs with pituitary-dependent hyperadrenocorticism.
Van Wijk PA; Rijnberk A; Croughs RJ; Voorhout G; Sprang EP; Mol JA
Endocrinology; 1992 Dec; 131(6):2659-62. PubMed ID: 1332844
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
[TBL] [Abstract][Full Text] [Related]
16. Serum cortisol concentrations in dogs with pituitary-dependent hyperadrenocorticism and atypical hyperadrenocorticism.
Frank LA; Henry GA; Whittemore JC; Enders BD; Mawby DI; Rohrbach BW
J Vet Intern Med; 2015 Jan; 29(1):193-9. PubMed ID: 25411029
[TBL] [Abstract][Full Text] [Related]
17. Utility of a corticotropin-releasing hormone test to differentiate pituitary-dependent hyperadrenocorticism from cortisol-producing adrenal tumors in dogs.
Tanaka S; Suzuki S; Sato A; Teshima T; Mori A; Sako T; Tanaka A; Hara Y
J Vet Intern Med; 2022 Jan; 36(1):29-38. PubMed ID: 34859496
[TBL] [Abstract][Full Text] [Related]
18. Plasma aldosterone concentrations and plasma renin activity in healthy dogs and dogs with hyperadrenocorticism.
Javadi S; Kooistra HS; Mol JA; Boer P; Boer WH; Rijnberk A
Vet Rec; 2003 Oct; 153(17):521-5. PubMed ID: 14620551
[TBL] [Abstract][Full Text] [Related]
19. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985-1995).
Van Liew CH; Greco DS; Salman MD
J Am Vet Med Assoc; 1997 Aug; 211(3):322-5. PubMed ID: 9262671
[TBL] [Abstract][Full Text] [Related]
20. Na(+), K(+)-ATPase content in skeletal muscle of dogs with pituitary-dependent hyperadrenocorticism.
Schotanus BA; Meij BP; Vos IH; Kooistra HS; Everts ME
Domest Anim Endocrinol; 2006 May; 30(4):320-32. PubMed ID: 16202554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
